This would account for the slightly increased levels of CD8+ T cells observed in the PBMCs of the participants from the Exitus group since the Week 6 of hospitalization onwards, despite the total levels of lymphocytes remaining unchanged and above the threshold of lymphopenia, also indicating a potential reduction of CD4+ T cells. The gene discussed is CD8A; the disease is lymphopenia.